Clinical trials recruiting for Borderline Resectable Pancreatic Ductal Adenocarcinoma
7
Recruiting trials
4
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Early Phase 1 1Phase 1 2Phase 2 2Not applicable 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Cisplatin | 2 |
| Gemcitabine | 2 |
| Azenosertib | 1 |
| Cobimetinib | 1 |
| Durvalumab | 1 |
| Fluorouracil | 1 |
| Genetic Testing | 1 |
| Irinotecan | 1 |
| Leucovorin | 1 |
| Ligritinib | 1 |
| Nab-paclitaxel | 1 |
| Olaparib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Georgia | 2 |
| California | 1 |
| Oregon | 1 |
| Washington | 1 |
Top cities
Self-screener
Recruiting trials
- AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
- Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
- Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
- PULSAR in Systemic Therapy for Pancreatic Cancer
- Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer
- Targeted Pathway Inhibition in Patients With Pancreatic Cancer
- Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment
Related conditions
Trials recruiting for Borderline Resectable Pancreatic Ductal Adenocarcinoma often also study these conditions. Each links to its own recruiting-trial list.
Pancreatic cancer 870Resectable Pancreatic Ductal Adenocarcinoma 5Locally Advanced Pancreatic Ductal Adenocarcinoma 8Stage III Pancreatic Cancer AJCC v8 14Stage II Pancreatic Cancer AJCC v8 9Stage IV Pancreatic Cancer AJCC v8 19Stage I Pancreatic Cancer AJCC v8 5Resectable Pancreatic Adenocarcinoma 5Pancreatic Ductal Adenocarcinoma 64Metastatic Pancreatic Ductal Adenocarcinoma 12
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Borderline Resectable Pancreatic Ductal Adenocarcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.